OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2
Norah A. Alturki, Mutaib M. Mashraqi, Ahmad Alzamami, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4391-4391
Open Access | Times Cited: 52
Norah A. Alturki, Mutaib M. Mashraqi, Ahmad Alzamami, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4391-4391
Open Access | Times Cited: 52
Showing 1-25 of 52 citing articles:
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis
Shaban Ahmad, Akash Pratap Singh, Nagmi Bano, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132332-132332
Closed Access | Times Cited: 7
Shaban Ahmad, Akash Pratap Singh, Nagmi Bano, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132332-132332
Closed Access | Times Cited: 7
Computational Identification of Bioactive Molecules from Caralluma stalagmifera L. as Potential VEGFR2 Inhibitors for Endometriosis Treatment
Jesudass Joseph Sahayarayan, Balasubramanian Sivaprakasam, Soundar Rajan Kulanthaivel, et al.
Journal of Pharmaceutical Innovation (2025) Vol. 20, Iss. 1
Closed Access
Jesudass Joseph Sahayarayan, Balasubramanian Sivaprakasam, Soundar Rajan Kulanthaivel, et al.
Journal of Pharmaceutical Innovation (2025) Vol. 20, Iss. 1
Closed Access
Computational evaluation of Khaya ivorensis against plasmodium falciparum aminopeptidase N (PfM1AP) enzyme: Molecular docking, simulation and ADMET studies
Chinenye J. Ugwah‐Oguejiofor, Abayomi Emmanuel Adegboyega, Christiana Abimbola Salubi, et al.
Results in Chemistry (2025), pp. 102072-102072
Open Access
Chinenye J. Ugwah‐Oguejiofor, Abayomi Emmanuel Adegboyega, Christiana Abimbola Salubi, et al.
Results in Chemistry (2025), pp. 102072-102072
Open Access
Identification of possible antimalarial constituent(s) from the leaves of Ochna kibbiensis: A phytochemical, in vivo and in silico approaches
A. J. Yusuf, Musa Abdullahi, Idris Nasir Abdullahi, et al.
Phytomedicine Plus (2025) Vol. 5, Iss. 2, pp. 100764-100764
Closed Access
A. J. Yusuf, Musa Abdullahi, Idris Nasir Abdullahi, et al.
Phytomedicine Plus (2025) Vol. 5, Iss. 2, pp. 100764-100764
Closed Access
Neuroprotective potential of 17-oximino-16-arylidene steroids: In vivo and in silico investigations
Ranjit Singh, Prerna Prerna, Ranju Bansal
European Journal of Pharmacology (2025), pp. 177467-177467
Closed Access
Ranjit Singh, Prerna Prerna, Ranju Bansal
European Journal of Pharmacology (2025), pp. 177467-177467
Closed Access
Assessing novel analogues of nilutamide as a human androgen receptor antagonist: A detailed investigation of drug design using a bioisosteric methodology including ADMET profiling, molecular docking studies and molecular dynamics simulation
Ajay Gupta, Yogita Sahu, Dipti Pal, et al.
Computational Biology and Chemistry (2025), pp. 108424-108424
Closed Access
Ajay Gupta, Yogita Sahu, Dipti Pal, et al.
Computational Biology and Chemistry (2025), pp. 108424-108424
Closed Access
Computational screening and MM/GBSA-based MD simulation studies reveal the high binding potential of FDA-approved drugs againstCutibacterium acnessialidase
Akash Pratap Singh, Shaban Ahmad, Khalid Raza, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6245-6255
Closed Access | Times Cited: 11
Akash Pratap Singh, Shaban Ahmad, Khalid Raza, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6245-6255
Closed Access | Times Cited: 11
Unveiling promising phytocompounds from Moringa oleifera as dual inhibitors of EGFR(T790M/C797S) and VEGFR-2 in non-small cell lung cancer through in silico screening, ADMET, dynamics simulation, and DFT analysis
Md. Masudur Rahman Munna, Md Touki Tahamid Tusar, Saima Sajnin Shanta, et al.
Journal of Genetic Engineering and Biotechnology (2024) Vol. 22, Iss. 3, pp. 100406-100406
Closed Access | Times Cited: 3
Md. Masudur Rahman Munna, Md Touki Tahamid Tusar, Saima Sajnin Shanta, et al.
Journal of Genetic Engineering and Biotechnology (2024) Vol. 22, Iss. 3, pp. 100406-100406
Closed Access | Times Cited: 3
Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid’s Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations
Mohammed Ageeli Hakami, Ali Hazazi, Fawaz Albloui, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 592-592
Open Access | Times Cited: 2
Mohammed Ageeli Hakami, Ali Hazazi, Fawaz Albloui, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 592-592
Open Access | Times Cited: 2
Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor
Hassan H. Almasoudi, Mutaib M. Mashraqi, Saleh Alshamrani, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 208-208
Open Access | Times Cited: 2
Hassan H. Almasoudi, Mutaib M. Mashraqi, Saleh Alshamrani, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 208-208
Open Access | Times Cited: 2
Repurposing FDA-approved drugs as NLRP3 inhibitors against inflammatory diseases: machine learning and molecular simulation approaches
Vipul Agarwal, Rajesh Haldhar, Abdurahman Hajinur Hirad, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-13
Closed Access | Times Cited: 2
Vipul Agarwal, Rajesh Haldhar, Abdurahman Hajinur Hirad, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-13
Closed Access | Times Cited: 2
Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach
Ahad Amer Alsaiari, Amal F. Gharib, Maha M. Bakhuraysah, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access | Times Cited: 2
Ahad Amer Alsaiari, Amal F. Gharib, Maha M. Bakhuraysah, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access | Times Cited: 2
Antimigraine activity of Asarinin by OPRM1 pathway with multifaceted impacts through network analysis
Rapuru Rushendran, Vellapandian Chitra
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Rapuru Rushendran, Vellapandian Chitra
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study
Saad Alghamdi, Hanadi M. Baeissa, Mohammad Azhar Kamal, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 16, pp. 8268-8280
Closed Access | Times Cited: 7
Saad Alghamdi, Hanadi M. Baeissa, Mohammad Azhar Kamal, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 16, pp. 8268-8280
Closed Access | Times Cited: 7
Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study
Hassan H. Almasoudi, Mohammed Ageeli Hakami, Abdulfattah Yahya M. Alhazmi, et al.
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 5
Hassan H. Almasoudi, Mohammed Ageeli Hakami, Abdulfattah Yahya M. Alhazmi, et al.
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 5
GEMIN4 Variants: Risk Profiling, Bioinformatics, and Dynamic Simulations Uncover Susceptibility to Bladder Carcinoma
Abdallah Mohamed, Afrah F. Salama, Magdy A. Sabaa, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 3, pp. 102970-102970
Open Access | Times Cited: 1
Abdallah Mohamed, Afrah F. Salama, Magdy A. Sabaa, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 3, pp. 102970-102970
Open Access | Times Cited: 1
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer
Abdulkarim S. Binshaya, Omar Saad Alkahtani, Fahad M. Aldakheel, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access | Times Cited: 1
Abdulkarim S. Binshaya, Omar Saad Alkahtani, Fahad M. Aldakheel, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access | Times Cited: 1
Phytoconstituents of Citrus limon (Lemon) as Potential Inhibitors Against Multi Targets of SARS‐CoV‐2 by Use of Molecular Modelling and In Vitro Determination Approaches
Kannan Raman, Kalirajan Rajagopal, Fahadul Islam, et al.
ChemistryOpen (2024)
Open Access | Times Cited: 1
Kannan Raman, Kalirajan Rajagopal, Fahadul Islam, et al.
ChemistryOpen (2024)
Open Access | Times Cited: 1
Exploring novel Apalutamide analogues as potential therapeutics for prostate cancer: design, molecular docking investigations and molecular dynamics simulation
Ajay Gupta, Yogesh Vaishnav, Sanmati K. Jain, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Ajay Gupta, Yogesh Vaishnav, Sanmati K. Jain, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Unveiling the multitargeted potential of deprodone and control comparison with linezolid against hydrolase and transferase enzymes of methicillin-resistant Staphylococcus aureus
Fawaz M. Almufarriji, Bader S. Alotaibi, Ahlam Saleh Alamri, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135459-135459
Closed Access | Times Cited: 1
Fawaz M. Almufarriji, Bader S. Alotaibi, Ahlam Saleh Alamri, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135459-135459
Closed Access | Times Cited: 1
Naphthoquinone fused diazepines targeting hyperamylasemia: potential therapeutic agents for diabetes and cancer
Sandhya Chahal, Payal Rani, Rajvir Singh, et al.
Future Medicinal Chemistry (2024), pp. 1-15
Closed Access | Times Cited: 1
Sandhya Chahal, Payal Rani, Rajvir Singh, et al.
Future Medicinal Chemistry (2024), pp. 1-15
Closed Access | Times Cited: 1
Discovery of natural compounds as novel FMS-like tyrosine kinase-3 (FLT3) therapeutic inhibitors for the treatment of acute myeloid leukaemia: an in-silico approach
Uddalak Das, C Lavanya, Akshay Uttarkar, et al.
Aspects of Molecular Medicine (2024), pp. 100058-100058
Open Access | Times Cited: 1
Uddalak Das, C Lavanya, Akshay Uttarkar, et al.
Aspects of Molecular Medicine (2024), pp. 100058-100058
Open Access | Times Cited: 1
Current trends on the application of artificial intelligence in medical sciences
Aisha Mousa Mashraqi
Bioinformation (2022) Vol. 18, Iss. 11, pp. 1050-1061
Open Access | Times Cited: 8
Aisha Mousa Mashraqi
Bioinformation (2022) Vol. 18, Iss. 11, pp. 1050-1061
Open Access | Times Cited: 8
Computational assessment of chemicals from Morinda citrifolia as potential inhibitors of B-Raf kinase in hepatocellular carcinoma treatment
Chinenye J. Ugwah‐Oguejiofor, Emeka Chukwuka, Olayinka Onifade, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 13271-13286
Closed Access | Times Cited: 4
Chinenye J. Ugwah‐Oguejiofor, Emeka Chukwuka, Olayinka Onifade, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 13271-13286
Closed Access | Times Cited: 4
